HCA Healthcare (HCA)
(Delayed Data from NYSE)
$397.50 USD
-5.93 (-1.47%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $397.50 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$397.50 USD
-5.93 (-1.47%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $397.50 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Zacks News
Why Is Universal Health Services (UHS) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Buy McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
by Zacks Equity Research
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
Universal Health (UHS) Q2 Earnings Beat on Strong Segments
by Zacks Equity Research
Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.
Company News for Jul 25, 2022
by Zacks Equity Research
Companies In The News Are: VZ, AXP, HCA, NEE.
Beat the Market the Zacks Way: NetEase, HCA, Intuit, Illinois Tool Works in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our last week's achievements.
HCA Healthcare (HCA) Q2 Earnings Beat on Better Patient Volumes
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect improved revenues stemming from better same-facility emergency room visits. However, the results were partly offset by elevated salaries and benefits cost.
HCA Healthcare (HCA) Beats Q2 Earnings Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 14.71% and 0.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results are likely to benefit from better patient volumes. The results might partly suffer from escalating labor costs that might dampen bottom line growth.
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $171.69, marking a +0.05% move from the previous day.
Earnings Preview: Universal Health Services (UHS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $169.39 in the latest trading session, marking a -1.86% move from the prior day.
HCA Healthcare (HCA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $172.58, marking a -1.42% move from the previous day.
Here's Why You Should Retain McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Acadia Healthcare (ACHC) JV to Build Behavioral Health Hospital
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a JV with Massachusetts-based Tufts Medicine to construct a behavioral health hospital and address the dire need for better behavioral healthcare services across Boston.
Stock Market News for Jul 1, 2022
by Zacks Equity Research
U.S. stocks ended lower on Thursday, with the S&P recording its worst first-half performance in more than 50 years.
HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV
by Zacks Equity Research
HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics market.
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $179.82 in the latest trading session, marking a -1.38% move from the prior day.
McKesson's (MCK) Latest JV to Boost Cancer Treatment Options
by Zacks Equity Research
McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.
HCA Healthcare (HCA) Scraps Utah Buyout Post FTC's Roadblock
by Zacks Equity Research
HCA Healthcare's (HCA) aborted acquisition follows another abandoned buyout plan involving RWJBarnabas Health and Saint Peter's Healthcare System.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $173.10, moving +0.9% from the previous trading session.
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $181.69, marking a +1.34% move from the previous day.
Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas
by Zacks Equity Research
Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.
HCA Healthcare's (HCA) Galen College Adds 8th New Facility
by Zacks Equity Research
HCA Healthcare's (HCA) Galen College nursing campus addition comes when the country is suffering from a nursing shortage.